TWiV 1320: Clinical update with Dr. Daniel Griffin
By Vincent Racaniello on May 09, 2026 12:00 am
In his weekly clinical update, Dr. Griffin and Vincent Racaniello discuss the outbreak of Hantavirus on a cruise ship and its potential for person-person transmission, how cessation of funding for global health by the Trump administration has compromised American health and well being, as well as the description of paralytic poliomyelitis outbreaks in Central Africa associated with the administration of nOPV2, before Dr. Griffin deep dives into the measles outbreak, recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, association of ear infections in children with RSV, PEMGARDA authorized use for certain immunocompromised individuals where to find PEMGARDA, how to access and pay for Paxlovid, where to go for answers about long COVID-19, multisystem inflammatory syndrome in children and contacting your federal government representative to stop the assault on science and biomedical research.Subscribe (free): Apple Podcasts, RSS, email
Become a patron of TWiV!Links for this episode
- Hantavirus Pulmonary Syndrome—The 25th Anniversary of the Four Corners Outbreak (CDC: Emerging Infectious Diseases)
- Outbreak of Hantavirus Infection in the Four Corners Region of the United States in the Wake of the 1997–1998 El Nino—Southern Oscillation (JID)
- Person-to-Person Transmission of Andes Virusin Hantavirus Pulmonary Syndrome, Argentina, 2014 (CDC: Emerging Infectious Diseases)
- Hantavirus cluster linked to cruise ship travel, Multi-country (WHO)
- Hantavirus (WHO)
- Ventilation Upgrade Reduces Fuel Consumption by 10 Percent in Cruise Ships(Halton)
- Person-to-Person Transmission of Andes Virusin Hantavirus Pulmonary Syndrome, Argentina, 2014 (CDC: Emerging Infectious Diseases)
- Incubation Period of Hantavirus Cardiopulmonary Syndrome (CDC: Emerging Infectious Diseases)
- At least 8 sickened in suspected hantavirus outbreak; Andes strain confirmed
- (CIDRAP)
- Hantavirus in humans: a review of clinical aspects and management (LANCET: Infectious Diseases)
- Cruise ship’s hantavirus outbreak puts researchers in uncharted territory (Science)
- Hantavirus Response Shows How Trump Cuts Have Compromised U.S. Preparedness (NY Times)
- Hantavirus on board with Prof. Vincent Racaniello (microbeTV)
- Emergence of vaccine-derived poliovirus strains from the novel oral polio vaccine in the Central African Republic (mBio)
- TWiV 1319: An earful of SARS-CoV-2 (microbeTV)
- Poliomyelitis (polio) (WHO)
- The world’s largest and highest-quality first-party data company (Dynata)
- MMR vaccine hesitancy in a polarized information ecosystem: Results from a cross-sectional survey of US adults (Vaccine)
- CDC communication undermines trust in vaccines (Science)
- F.D.A. Blocked Publication of Research Finding Covid and Shingles Vaccines Were Safe (NY Times)
- Tick Bite Data Tracker (CDC: Ticks)
- Infectious Diseases(POPHIVE: Yale School of Public Health)
- The National Respiratory and Enteric VirusSurveillance System (NREVSS) (CDC: National Respiratory and enteric virus surveillance System)
- Wastewater for measles (WasterWater Scan)
- Measles cases and outbreaks(CDC Rubeola)
- Big outbreak, bright lights…Measles Dashboard (South Carolina Department of Public Health)
- Utah measles outbreak response (Utah Department of Health and Human Services)
- Utah Measles Dashboard (Utah Department of Health and Human Services)
- Tracking Measles Cases in the U.S. (Johns Hopkins)
- Measles vaccine recommendations from NYP (jpg)
- Weekly measles and rubella monitoring (Government of Canada)
- Measles (WHO)
- Get the FACTS about measles (NY State Department of Health)
- Measles vaccine (CDC Measles (Rubeola))
- Presumptive evidence of measles immunity (CDC)
- Contraindications and precautions to measles vaccination (CDC)
- Measles (CDC Measles (Rubeola))
- Adverse events associated with childhood vaccines: evidence bearing on causality (NLM)
- Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America)
- Deaths following vaccination: what does the evidence show(Vaccine)
- Will the USA lose its measles elimination status? (LANCET)
- Influenza: Waste water scan for 11 pathogens(WastewaterSCan)
- US respiratory virus activity (CDC Respiratory Illnesses)
- Respiratory virus activitylevels (CDC Respiratory Illnesses)
- Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA)
- WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP)
- FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP)
- Weekly surveillance report: cliff notes (CDC FluView)
- OPTION 2: XOFLUZA $50 Cash Pay Option(xofluza)
- RSV: Waste water scan for 11 pathogens (WastewaterSCan)
- Respiratory Diseases (Yale School of Public Health)
- US respiratory virus activity (CDC Respiratory Illnesses)
- RSV-Network (CDC Respiratory Syncytial virus Infection)
- Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV))
- Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP)
- Respiratory Diseases (Yale School of Public Health)
- Impact of Respiratory Syncytial Virus Immunizationon the Rate of Pediatric Acute Otitis Media: A Time-series Analysis (CID)
- Waste water scan for 11 pathogens (WastewaterSCan)
- COVID-19 deaths (CDC)
- Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses)
- COVID-19 national and regional trends (CDC)
- COVID-19 variant tracker(CDC)
- SARS-CoV-2 genomes galore (Nextstrain)
- Where to get pemgarda (Pemgarda)
- EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD)
- Infusion center (Prime Fusions)
- CDC Quarantine guidelines (CDC)
- NIH COVID-19 treatment guidelines (NIH)
- Drug interaction checker(University of Liverpool)
- Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro)
- Understanding CoverageOptions (PAXCESS)
- Infectious Disease Society guidelines for treatment and management (ID Society)
- Molnupiravir safety and efficacy (JMV)
- Convalescent plasma recommendation for immunocompromised (ID Society)
- What to do when sick with a respiratory virus (CDC)
- Managing healthcare staffing shortages (CDC)
- Anticoagulation guidelines (hematology.org)
- Daniel Griffin’s evidence based medical practices for long COVID (OFID)
- Long COVID hotline(Columbia : Columbia University Irving Medical Center)
- The answers: Long COVID
- Multisystem inflammatory syndrome in children (MIS-C), United States, 2023–2024 (CID)
- Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID (Communications Medicine)
- Reaching out to US house representative
- Letters read on TWiV 1320
- Dr. Griffin’s COVID treatment summary (pdf)
- Timestamps by Jolene Ramsey. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
Content in this podcast should not be construed as medical advice.
Read in browser »